Literature DB >> 11774105

Clinical and demographic predictors of exercise capacity in end-stage renal disease.

Kathy E Sietsema1, William R Hiatt, Anne Esler, Sharon Adler, Antonino Amato, Eric P Brass.   

Abstract

Patients on maintenance hemodialysis therapy for end-stage renal disease have reduced exercise tolerance. Multiple processes related to uremia and hemodialysis have been implicated in the pathophysiology of this impairment. However, limited data are available to identify the separate and combined effects of clinical factors on the degree of impairment for individuals within this population. For this purpose, data from 193 patients who had undergone exercise testing for two clinical trials were retrospectively analyzed. Univariate and multiple linear regression analyses were used to identify demographic and clinical correlates of peak exercise oxygen uptake (VO2). Peak VO2 averaged 18.5 +/- 6.4 mL/min/kg. On univariate analysis, peak VO2 correlated positively with male sex and hemoglobin, serum albumin, and serum creatinine concentrations and correlated negatively with dialytic age and diagnosis of diabetes or chronic heart failure. In a multiple linear regression model, sex, hemoglobin concentration, age, and diagnosis of diabetes each remained statistically significant. Together, factors included in the model accounted for 41% of the variability in peak VO2 (P = 0.0001). Among factors not correlating significantly with peak VO2 were resting blood pressure, serum carnitine level, and urea clearance assessed by Kt/V. Findings show the range of exercise impairment among clinically stable ambulatory hemodialysis patients, which may be sufficient to interfere with normal daily activities for many of these patients. Although this impairment may be broadly attributable to physiological consequences of uremia, the degree of impairment for individual patients is predicted by demographic factors, coexistent disease, and factors potentially modified by medical therapeutics. Copyright 2002 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11774105     DOI: 10.1053/ajkd.2002.29884

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  16 in total

1.  Effects of modality change and transplant on peak oxygen uptake in patients with kidney failure.

Authors:  Patricia Painter; Joanne B Krasnoff; Michael Kuskowski; Lynda Frassetto; Kirsten L Johansen
Journal:  Am J Kidney Dis       Date:  2010-09-25       Impact factor: 8.860

2.  Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease.

Authors:  Bradley A Warady; Mazen Y Arar; Gary Lerner; Arline M Nakanishi; Catherine Stehman-Breen
Journal:  Pediatr Nephrol       Date:  2006-05-25       Impact factor: 3.714

3.  Effect of Chronic Kidney Disease and Supplemental Polyunsaturated Fatty Acid Use on Exercise Levels During Cardiac Rehabilitation in Patients With Coronary Artery Disease.

Authors:  Adam Pflum; Pallavi Gomadam; Hardik Mehta; Matthew Sacrinty; Connie C Paladenech; Killian Robinson
Journal:  J Cardiopulm Rehabil Prev       Date:  2017-05       Impact factor: 2.081

4.  Endothelial dysfunction correlates with exaggerated exercise pressor response during whole body maximal exercise in chronic kidney disease.

Authors:  Ryan M Downey; Peizhou Liao; Erin C Millson; Arshed A Quyyumi; Salman Sher; Jeanie Park
Journal:  Am J Physiol Renal Physiol       Date:  2017-03-08

Review 5.  Inflammation and cachexia in chronic kidney disease.

Authors:  Wai W Cheung; Kyung Hoon Paik; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2010-01-29       Impact factor: 3.714

Review 6.  Abnormal neurocirculatory control during exercise in humans with chronic renal failure.

Authors:  Jeanie Park; Holly R Middlekauff
Journal:  Auton Neurosci       Date:  2014-10-22       Impact factor: 3.145

7.  Intradialytic cycling in children and young adults on chronic hemodialysis.

Authors:  Fabio Paglialonga; Amalia Lopopolo; Rosalia Viviana Scarfia; Silvia Consolo; Maria Albina Galli; Simona Salera; Maria Rosa Grassi; Anna Brivio; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2013-11-21       Impact factor: 3.714

8.  Tetrahydrobiopterin ameliorates the exaggerated exercise pressor response in patients with chronic kidney disease: a randomized controlled trial.

Authors:  Ann M Lin; Peizhou Liao; Erin C Millson; Arshed A Quyyumi; Jeanie Park
Journal:  Am J Physiol Renal Physiol       Date:  2016-03-09

9.  Motor performance, exercise tolerance, and health-related quality of life in children on dialysis.

Authors:  Rian M Eijsermans; Desiree G Creemers; Paul J Helders; Cock H Schröder
Journal:  Pediatr Nephrol       Date:  2004-09-11       Impact factor: 3.714

10.  Decreased maximal aerobic capacity in pediatric chronic kidney disease.

Authors:  Donald J Weaver; Thomas R Kimball; Timothy Knilans; Wayne Mays; Sandra K Knecht; Yvette M Gerdes; Sandy Witt; Betty J Glascock; Janis Kartal; Philip Khoury; Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2008-01-09       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.